AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · IEX Real-Time Price · USD
1.530
+0.030 (2.00%)
May 17, 2024, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $59.09 million as of May 17, 2024. Its market cap has decreased by -83.44% in one year.
Market Cap
59.09M
Enterprise Value
53.93M
1-Year Change
-83.44%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since February 9, 2021, AEON Biopharma's market cap has decreased from $259.00M to $59.09M, a decrease of -77.19%. That is a compound annual growth rate of -36.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 59.90M | 2.04% |
May 16, 2024 | 58.70M | -5.02% |
May 15, 2024 | 61.80M | -3.13% |
May 14, 2024 | 63.80M | 0.47% |
May 13, 2024 | 63.50M | -2.91% |
May 10, 2024 | 65.40M | 4.31% |
May 9, 2024 | 62.70M | -6.28% |
May 8, 2024 | 66.90M | 11.31% |
May 7, 2024 | 60.10M | -2.44% |
May 6, 2024 | 61.60M | -4.05% |
May 3, 2024 | 64.20M | -49.45% |
May 2, 2024 | 127.00M | -5.86% |
May 1, 2024 | 134.90M | -7.29% |
Apr 30, 2024 | 145.50M | -3.51% |
Apr 29, 2024 | 150.80M | -21.29% |
Apr 26, 2024 | 191.60M | 19.30% |
Apr 25, 2024 | 160.60M | 6.01% |
Apr 24, 2024 | 151.50M | -6.77% |
Apr 23, 2024 | 162.50M | -8.91% |
Apr 22, 2024 | 178.40M | 1.31% |
Apr 19, 2024 | 176.10M | -28.73% |
Apr 18, 2024 | 247.10M | -3.70% |
Apr 17, 2024 | 256.60M | -1.46% |
Apr 16, 2024 | 260.40M | -2.94% |
Apr 15, 2024 | 268.30M | -6.58% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Envoy Medical | 61.54M |
Kronos Bio | 61.30M |
Ocean Biomedical | 60.64M |
Genenta Science | 60.12M |
Anebulo Pharmaceuticals | 59.64M |
Augmedix | 58.76M |
Theratechnologies | 58.62M |
Reneo Pharmaceuticals | 58.49M |